Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Clinical Trial ID NCT00924170

Rank	Title	Journal	Year	PubWeight™‹?›
1	A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.	Nature	1982	9.42
2	Global epidemiology of HTLV-I infection and associated diseases.	Oncogene	2005	4.77
3	A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.	FEBS J	2011	1.70
4	Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.	J Clin Invest	1984	1.46
5	Immunotoxins for leukemia.	Blood	2014	1.33
6	Tumor-stromal interactions in pancreatic cancer.	Crit Rev Oncog	2013	1.01